Some clinical studies revealed that VEGF-C status in tumour cells was a significant prognostic predictor in gastric carcinoma (Yonemura et al, 1999; Ichikura et al, 2001) and cervical carcinoma (Hirai et al, 2001), and the clinical impact remains unclear. This evidence concerns the gene VEGFC and neoplasm.